Stay updated on Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial
Sign up to get notified when there's something new on the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page.

Latest updates to the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page
- Check6 days agoChange DetectedA site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2; the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content. The visible addition indicates access to the study record is blocked, while site chrome remains, signaling a restricted access state.SummaryDifference18%

- Check62 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6 on the page. This reflects a minor software version update and does not alter the study content or eligibility details.SummaryDifference0.1%

- Check69 days agoChange DetectedA new NIH grant/contract entry was added to the study's identifiers, signaling NIH funding for the trial.SummaryDifference0.1%

Stay in the know with updates to Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page.